-
1 Comment
co.don AG is currently in a long term uptrend where the price is trading 22.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.1.
Based on the above factors, co.don AG gets an overall score of 2/5.
| Sector | Healthcare |
|---|---|
| Industry | Biotechnology |
| Exchange | F |
| CurrencyCode | EUR |
| ISIN | DE000A1K0227 |
| Beta | 1.91 |
|---|---|
| Market Cap | 54M |
| PE Ratio | None |
| Target Price | 10.55 |
| Dividend Yield | 0.0% |
co.don AG, a biopharmaceutical company, develops, produces, and markets cell-based pharmaceutical products for joint preservation and the regenerative treatment of articular cartilage defects worldwide. It offers Spherox, a three dimensional chondrocyte product that is used to treat cartilage defects in adult knee joints; and co.don chondrosphere for the treatment of cartilage defects in the hip, ankle, shoulder and elbow, and knees of younger patients. The company serves accident and orthopedic surgeons. co.don AG was founded in 1993 and is headquartered in Teltow, Germany.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CNWK.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
